Search

Collegium Pharmaceutical Inc

Suletud

SektorTervishoid

27.33 0.48

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

26.69

Max

27.95

Põhinäitajad

By Trading Economics

Sissetulek

-30M

-15M

Müük

6.4M

200M

P/E

Sektori keskmine

22.228

57.371

Aktsiakasum

1.57

Kasumimarginaal

-7.53

Töötajad

423

EBITDA

-20M

71M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+81.67% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-279M

875M

Eelmine avamishind

26.85

Eelmine sulgemishind

27.33

Uudiste sentiment

By Acuity

32%

68%

104 / 340 Pingereas Healthcare

Collegium Pharmaceutical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. aug 2026, 22:02 UTC

Collegium Pharmaceutical shares advanced in after-market trading, despite being below their 20-day moving average and weaker compared to a month ago.

21. aug 2026, 20:13 UTC

Collegium Pharmaceutical Inc. shares are trading roughly flat after-market, with no specific news identified. The stock remains below its 20-day moving average.

20. aug 2026, 20:01 UTC

Collegium Pharmaceutical shares are lower amid broader market pressures, reflecting negative sentiment following Walmart's disappointing earnings report.

19. aug 2026, 19:56 UTC

Collegium Pharmaceutical Inc. shares are higher since Tuesday's close, reaching a session high earlier before pulling back within routine trading patterns.

18. aug 2026, 19:56 UTC

Collegium Pharmaceutical Inc is trading higher today, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

17. aug 2026, 19:36 UTC

Collegium Pharmaceutical Inc shares are higher during Monday's session, reaching a peak gain earlier today before retracing. No specific news was identified for the movement.

14. aug 2026, 19:21 UTC

Collegium Pharmaceutical Inc shares are lower today, reflecting a broader downturn in the Pharmaceuticals sector. The stock remains below its 20-day moving average.

13. aug 2026, 22:51 UTC

Collegium Pharmaceutical Inc shares rose in after-market trading, reflecting broader market gains amid unchanged producer prices and easing inflation expectations.

12. aug 2026, 19:51 UTC

Collegium Pharmaceutical Inc's shares are lower today, continuing a trend of recent weakness amid unusually high market volume. No specific news was identified.

11. aug 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are higher in after-market trading, reversing earlier session dips and showing strength after three consecutive lower closes.

10. aug 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a trend since Monday's close, and are significantly below their 20-day moving average.

7. aug 2026, 21:01 UTC

Collegium Pharmaceutical Inc shares are trading higher in after-market hours. No specific news was identified to explain the movement.

6. aug 2026, 23:11 UTC

Collegium Pharmaceutical Inc shares are higher in after-market hours, recovering from an initial dip but remain below their 20-day moving average.

4. aug 2026, 19:26 UTC

Collegium Pharmaceutical Inc shares are lower today, trading near the lower end of their one-month range, with no specific news driving the decline.

3. aug 2026, 19:46 UTC

Collegium Pharmaceutical Inc is trading lower today, continuing a three-session decline. The stock peaked early but has since pulled back.

31. juuli 2026, 20:06 UTC

News

Collegium Pharmaceutical is under scrutiny due to concerns over its financial performance, contributing to a decline in shares during Friday's session.

30. juuli 2026, 20:09 UTC

Collegium Pharmaceutical Inc shares are lower in Thursday's session, with no specific news to explain the decline amid broader market volatility.

29. juuli 2026, 22:01 UTC

Collegium Pharmaceutical Inc is trading higher in after-market hours, continuing a positive trend with gains over four consecutive sessions amid cautious investor sentiment.

28. juuli 2026, 22:01 UTC

Collegium Pharmaceutical Inc shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressures, particularly in Asia.

27. juuli 2026, 19:07 UTC

News

Collegium Pharmaceutical reported first-quarter revenues of $193.5 million, surpassing expectations, while shares are trading higher amid broader strength in the pharmaceutical sector.

24. juuli 2026, 19:46 UTC

Collegium Pharmaceutical Inc shares are lower during Friday's session, with no specific news identified to explain the decline. The stock remains near its one-month trading range.

22. juuli 2026, 20:01 UTC

Collegium Pharmaceutical Inc shares are lower today, continuing a downward trend seen since Tuesday's close, with no specific news identified for the decline.

21. juuli 2026, 20:01 UTC

Collegium Pharmaceutical Inc is trading higher amid a broader market rally, with the Pharmaceuticals sector also gaining momentum. No specific news was identified.

20. juuli 2026, 19:41 UTC

News

Collegium Pharmaceutical plans to move its headquarters to Boston in 2027. Shares are lower amid significant declines in the Pharmaceuticals sub-sector.

Võrdlus sarnastega

Hinnamuutus

Collegium Pharmaceutical Inc Prognoos

Hinnasiht

By TipRanks

81.67% tõus

12 kuu keskmine prognoos

Keskmine 49.25 USD  81.67%

Kõrge 60 USD

Madal 43 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Collegium Pharmaceutical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

3

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

104 / 340 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
help-icon Live chat